G&S Capital LLC Merck & Co., Inc. Transaction History

G&S Capital LLC

$252 Million
Q3 2025

A detailed history of G&S Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, G&S Capital LLC holds 7,621 shares of MRK stock, worth $707,686. This represents 0.25% of its overall portfolio holdings.

Number of Shares

7,621

Previous 7,674 0.69%

Holding current value

$707,686

Previous $607,000 5.27%

% of portfolio

0.25%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$77.6 - $87.37 $4,112 - $4,630	-53 Reduced 0.69%	7,621 $639,000
Q2 2025 Jul 17, 2025	BUY	$73.47 - $87.12 $37,616 - $44,605	512 Added 7.15%	7,674 $607,000
Q1 2025 Apr 25, 2025	BUY	$83.01 - $101.02 $594,517 - $723,505	7,162 New	7,162 $642,000
Q3 2024 Oct 16, 2024	BUY	$111.15 - $128.97 $60,576 - $70,288	545 Added 2.61%	21,405 $2.43 Million
Q2 2024 Jul 30, 2024	BUY	$123.8 - $132.96 $1.31 Million - $1.4 Million	10,564 Added 102.6%	20,860 $2.58 Million

Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $1.17 Million - $1.36 Million	10,296 New	10,296 $1.36 Million
Q1 2020 Apr 23, 2020	SELL	$63.36 - $87.82 $2.82 Million - $3.91 Million	-44,546 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$77.58 - $87.54 $3.46 Million - $3.9 Million	44,546 New	44,546 $4.05 Million
Q1 2019 Apr 22, 2019	SELL	$69.58 - $79.36 $5,566 - $6,348	-80 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$65.24 - $75.71 $5,219 - $6,056	80 New	80 $6,000
Q1 2018 Apr 25, 2018	SELL	$50.96 - $59.23 $270,088 - $313,919	-5,300 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $273,586 - $326,692	5,300	5,300 $298,000

Others Institutions Holding MRK

# of Institutions

3,877

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on G&S Capital LLC with notifications on news.

Account